Research Article
Dynamical Regulation Analysis Identifies Molecular Mechanisms of Fuzheng-Huayu Formula against Hepatitis B-Caused Liver Cirrhosis
Table 2
The potential kernel miRNAs selected by FZHY and Placebo treatments.
| Group A (FZHY related miRNAs) | Group B (Placebo related miRNAs) |
| has-miR-1207-5p | has-miR-765 | hsa-miR-19b-3p | hsa-miR-320d | hsa-miR-101-3p | hsa-miR-301b | has-miR-1268a | hsa-miR-101-3p | hsa-miR-21-5p | hsa-miR-340-5p | hsa-miR-1299 | hsa-miR-335-5p | has-miR-134 | hsa-miR-103a-3p | hsa-miR-221-3p | hsa-miR-374a-5p | hsa-miR-130a-3p | hsa-miR-33a-5p | has-miR-135a-3p | hsa-miR-128 | hsa-miR-25-3p | hsa-miR-374b-5p | hsa-miR-142-3p | hsa-miR-340-5p | has-miR-1471 | hsa-miR-142-5p | hsa-miR-26b-5p | hsa-miR-424-5p | hsa-miR-148b-3p | hsa-miR-363-3p | has-miR-26a-5p | hsa-miR-15a-5p | hsa-miR-27b-3p | hsa-miR-93-5p | hsa-miR-16-5p | hsa-miR-381-3p | has-miR-483-5p | hsa-miR-186-5p | hsa-miR-29c-3p | ā | hsa-miR-19b-3p | hsa-miR-410 | has-miR-663a | hsa-miR-19a-3p | hsa-miR-30e-3p | ā | hsa-miR-21-5p | hsa-miR-497-5p |
|
|